GLP-1 agonists have appeared to be superior to lifestyle management alone for losing weight and have better patient attrition rates
This can promote cancer growth and resistance to treatment
Key takeaway: GLP-1 medications like tirzepatide and semaglutide can affect the menstrual cycle, typically due to hormonal shifts related to rapid weight loss and metabolic changes
Oregon, Washington, Idaho, and Utah Medicaid programs cover SGLT-2 inhibitors for T2D
We at Obesity UK are very concerned to hear reports that people living with obesity are falling victim to criminals who are obtaining and selling fake weight loss medication, said Professor Paul Gately, CEO of Obesity UK, in a statement
Among people who were prescribed a GLP-1 medication for weight loss such as semaglutide (branded as Ozempic and Wegovy), exenatide (Byetta) and liraglutide (Victoza) 10 out of every 10,000, or 0.1%, were diagnosed with gastroparesis at least six months later